… J Rosing, KWM Bloemenkamp, S Middeldorp … - New England Journal of Medicine, 2001 - content.nejm.org Arterial thrombosis is also a complication of oral-contraceptive therapy, but
the risk factors for this condition differ from those for venous thrombosis. For
example, smoking increases the risk of myocardial infarction associated ... Cited by 297 - Related articles - BL Direct - All 11 versions
J Rosing, S Middeldorp, J Curvers, M … - The Lancet, 1999 - Elsevier We have reported previously that, compared with use of second-generation oral
contraceptives, the use of third-generation oral contraceptives is associated
with increased resistance to the anticoagulant action of activated protein ... Cited by 152 - Related articles - All 7 versions
G Sarig, JS Younis, R Hoffman, N Lanir, Z … - Fertility and sterility, 2002 - Elsevier Presented at the XVII Congress of the International Society on Thrombosis and
Hemostasis, Washington, DC, August 14–21, 1999, and at the 41st Congress of
the American Society of Hematology, New Orleans, December 3–7, 1999. Cited by 123 - Related articles - BL Direct - All 10 versions
WW Grody, JH Griffin, AK Taylor, BR Korf, JA … - Genetics in Medicine, 2001 - journals.lww.com Recommendation 1 When appropriate clinical care requires testing for the factor
V Leiden allele, either direct DNA-based genotyping or a factor V
Leiden-specific functional assay is recommended. Patients who test positive ... Cited by 124 - Related articles - BL Direct - All 4 versions
- ►annals.org [PDF] MA Crowther, JG Kelton - Annals of internal medicine, 2003 - Am Coll Physicians Congenital causes of venous thrombosis have gained increasing prominence with
the description of the factor V Leiden mutation and the prothrombin gene
mutation. More recently, the descrip- tion of the association between ... Cited by 122 - Related articles - BL Direct - All 8 versions
- ►annals.org [PDF] S Middeldorp, JR Meinardi, MMW Koopman, E … - Annals of internal medicine, 2001 - Am Coll Physicians Background: The factor V Leiden mutation is a common genetic defect associated
with an increased risk for venous thromboem- bolism. The clinical implications
for asymptomatic carriers of this mutation and, consequently, the ... Cited by 120 - Related articles - All 11 versions
JL Kujovich - American journal of obstetrics and gynecology, 2004 - Elsevier Thrombophilic disorders are associated with an increased risk of fetal loss in
the majority of case control and cohort studies. The risk is increased
throughout pregnancy, but may be higher in the second and third trimester. ... Cited by 108 - Related articles - All 12 versions
- ►ahajournals.org PW Kamphuisen, JCJ Eikenboom, RM Bertina - Arteriosclerosis, thrombosis, and vascular biology, 2001 - Am Heart Assoc In vivo, a delicate balance exists between fibrin formation and fibrinolysis.
Reduced blood flow, changes in the vessel wall, and changes in blood composition
(hypercoagulability) 1 may all result in a disturbance of this balance, ... Cited by 105 - Related articles - BL Direct - All 6 versions
CA Solem, EV Loftus, WJ Tremaine, WJ … - The American journal of gastroenterology, 2004 - nature.com Presented in part at the 103rd Annual Meeting of the American
Gastroenterological Association, Digestive Disease Week, May 19–22, 2002, San
Francisco, California (Gastroenterology 2002;122:A606). Cited by 103 - Related articles - BL Direct - All 6 versions
- ►haematologica.com [PDF] V De Stefano, E Rossi, K Paciaroni, G Leone - Haematologica, 2002 - haematologica.org State of the Art. The associated risk for VTE is different according to
genotype, being higher among the carriers of natural anticoagulant deficiencies
and homozygotes for factor V Leiden. The overall prevalence of throm- ... Cited by 102 - Related articles - BL Direct - All 15 versions
